Dana Farber Community Cancer Care-Quincy — Quincy, Massachusetts

Dana Farber Community Cancer Care-Quincy is a clinical research site located in Quincy, Massachusetts, United States 02169.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Community Cancer Care-Quincy has participated in 13 clinical trials with 8 currently active.

Therapeutic areas: Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Community Cancer Care-Quincy?

Dana Farber Community Cancer Care-Quincy has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Community Cancer Care-Quincy conducted?

Dana Farber Community Cancer Care-Quincy has 13 clinical trials on record, with 8 currently active. Their work covers Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Is Dana Farber Community Cancer Care-Quincy accredited by Crixeo Health?

Yes — Dana Farber Community Cancer Care-Quincy holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana Farber Community Cancer Care-Quincy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.